insights_auto
Why is UTHR up 2.12%?
Dive Deeperchevron_right
UTHR:NASDAQ
United Therapeutics Corp
$485.54
arrow_upward
+2.12%(+10.09) 1D
$485.54
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 28, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UTHR...
Open
$473.84
High
$486.98
Low
$470.76
Mkt. cap
20.83B
Avg. vol.
640.14K
Volume
31.00
P/E ratio
17.37
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.56
Shares outstanding
42.89M
No. of employees
1K
Open
$473.84
High
$486.98
Low
$470.76
Mkt. cap
20.83B
Avg. vol.
640.14K
Volume
31.00
P/E ratio
17.37
52-wk high
$609.35
52-wk low
$409.15
EPS
$27.96
Beta
0.56
Shares outstanding
42.89M
No. of employees
1K
News stories
From web sources and news partners
Yahoo Finance
·
10 hours ago
United Therapeutics (UTHR): Goldman Says Sell As The Base Business Shrinks, But 2027 Holds Real Catalysts
Stock Titan
·
15 hours ago
After exercising stock options, the CEO’s family trust sold 9,500 United Therapeutics (UTHR) shares.
Yahoo Finance
·
1 day ago
What United Therapeutics (UTHR)'s Goldman Sell Call Amid Bold Pipeline And Buyback Means For Shareholders
Seeking Alpha
·
1 day ago
United Therapeutics: The Market Sees The Erosion, Not The Refill - Buy (NASDAQ:UTHR)
Profile
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire. Wikipedia
About United Therapeutics Corp
CEO-
Employees1.4K
Founded1996
HeadquartersSilver Spring, Maryland, United States
SectorBiotechnology
Websiteunither.com